DNA damage response and repair (DDR) gene mutations and correlation with tumor mutation burden (TMB) in non-small cell lung cancer (NSCLC).Hirva Mamdani, Shadia I. Jalal, Rebecca Feldman et al.|Journal of Clinical Oncology|2019Cited by 13
Correlation between K-RAS mutant subsets, TP53 mutation, and PD-L1 status in non-small cell lung cancer (NSCLC).Nagla Fawzy Abdel Karim, Abdul Rafeh Naqash, Chisom Onuoha et al.|Journal of Clinical Oncology|2019Cited by 2
Co-mutational status and PD-L1 expression in <i>KRAS</i> mutant non-small cell lung cancer (NSCLC): Role in treatment selection and association with clinical outcomes.Hina Khan, Nagla Fawzy Abdel Karim, Julia Judd et al.|Journal of Clinical Oncology|2023Cited by 2